These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7811058)

  • 1. Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes.
    Zelphati O; Wagner E; Leserman L
    Antiviral Res; 1994 Sep; 25(1):13-25. PubMed ID: 7811058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
    Zelphati O; Zon G; Leserman L
    Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
    Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
    Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV replication by immunoliposomal antisense oligonucleotide.
    Selvam MP; Buck SM; Blay RA; Mayner RE; Mied PA; Epstein JS
    Antiviral Res; 1996 Dec; 33(1):11-20. PubMed ID: 8955849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
    Bongartz JP; Aubertin AM; Milhaud PG; Lebleu B
    Nucleic Acids Res; 1994 Nov; 22(22):4681-8. PubMed ID: 7984418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides.
    Hatta T; Nakagawa Y; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1996 Jun; 223(2):341-6. PubMed ID: 8670284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically active oligodeoxyribonucleotides--I: Syntheses and anti-HIV-1 activities of 5'-modified pentadecadeoxyribonucleotides.
    Hotoda H; Momota K; Furukawa H; Nakamura T; Kaneko M; Kimura S; Shimada K
    Nucleic Acids Symp Ser; 1993; (29):59-61. PubMed ID: 8247795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C; Yelle J; Sauve G; Thierry AR
    AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.
    Ma DD; Wei AQ
    Leuk Res; 1996; 20(11-12):925-30. PubMed ID: 9009250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
    Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
    Krieg AM; Tonkinson J; Matson S; Zhao Q; Saxon M; Zhang LM; Bhanja U; Yakubov L; Stein CA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1048-52. PubMed ID: 8430072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
    Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
    Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.
    Düzgüneş N; Pretzer E; Simões S; Slepushkin V; Konopka K; Flasher D; de Lima MC
    Mol Membr Biol; 1999; 16(1):111-8. PubMed ID: 10332745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempts to use liposomes and RBC ghosts as vectors in drug and antisense therapy of virus infection.
    Grimaldi S; Lisi A; Pozzi D; Santoro N
    Res Virol; 1997; 148(2):177-80. PubMed ID: 9108622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents.
    Morvan F; Porumb H; Degols G; Lefebvre I; Pompon A; Sproat BS; Rayner B; Malvy C; Lebleu B; Imbach JL
    J Med Chem; 1993 Jan; 36(2):280-7. PubMed ID: 8423598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus-1 proliferation by liposome-encapsulated sense DNA to the 5' tat splice acceptor site.
    Sullivan SM; Gieseler RK; Lenzner S; Ruppert J; Gabrysiak TG; Peters JH; Cox G; Richer L; Martin WJ; Scolaro MJ
    Antisense Res Dev; 1992; 2(3):187-97. PubMed ID: 1490070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides.
    Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R
    Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups.
    Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV
    Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
    Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S
    Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.